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Abstract
Left ventricular non-compaction (LVNC) is a rare congenital phenotype deﬁned by the presence of prominent left
ventricular trabeculae, deep intertrabecular recesses (continuous with the ventricular cavity), and a thin compacted layer.
The most common presentation of LVNC is dyspnea (60%), followed by palpitations (18%), chest pain (15%), syncope
(9%), and prior stroke (3%). LVNC presenting with acute myocardial infarction (MI) has rarely been reported in the
literature. A forty-one-years old female presented with substernal chest pain and exertional dyspnea. On physical examination, she was alert without any distress, her lungs and heart examination were within normal limits. Peripheral
pulses were palpable and regular, and þ1 peripheral pitting edema was noted. EKG showed normal sinus rhythm with
premature atrial contractions (PACs), left axis deviation, and ST-segment and T wave changes suggestive of inferior wall
ischemia. Troponin I level was found to be elevated, which peaked within 24 hours, Troponinmax 110.08 ng/ml.
Transthoracic echocardiography showed moderate LV dilatation with severely reduced EF (15e20%), and diffuse LV
hypokinesis with a grade III restrictive pattern. There was heavy trabeculation of LV involving 2/3rd LV endocardium
and wall thickness with sinusoidal tunnels perpendicular to LV wall. These morphological ﬁndings met the diagnostic
criteria of LVNC/NCM. LVNC presenting with acute myocardial infarction (MI) can be related to poor outcomes,
however, more data is needed to establish the clinical implication of this presentation. Asymptomatic LVNC can be
observed while symptomatic LVNC should be treated with standard guidelines of HF.
Keywords: Cardiomyopathy, Myocardial infarction, Heart failure, Noncompaction

1. Introduction

L

eft ventricular non-compaction (LVNC) is a
rare congenital phenotype deﬁned by the
presence of prominent left ventricular trabeculae,
deep intertrabecular recesses (continuous with the
ventricular cavity), and a thin compacted layer. It is
suggested that the origin of LVNC is attributable to
arrested compaction or failure in the solidiﬁcation of
the myocardial primordium during embryogenesis.
Thickened myocardium consists of two distinct
layers; a thin compacted epicardial layer and a
thickened non-compacted endocardial layer. Isolated LVNC does not imply LV dysfunction and it

can be observed in asymptomatic individuals with
normal LV size and wall thickness. However, LVNC
can present with dilated, restrictive, or hypertrophic
cardiomyopathy.1,2 The prevalence of LVNC in the
general population is not known, an estimated
prevalence of 0.014e1.3% has been noted among
patients undergoing echocardiography.3 NCM can
be sporadic or familial. However, a higher prevalence (3e4%) has been reported among patients
with heart failure.4 Almost 12e50% of reported
cases have a positive family history of noncompaction cardiomyopathy with variable inheritance patterns including autosomal dominant, X
linked, and autosomal recessive inheritance.5 The
most common presentation of LVNC is dyspnea

Received 8 June 2022; revised 24 August 2022; accepted 31 August 2022.
Available online 7 November 2022
* Corresponding author.
E-mail address: gaurav.mohan@rwjbh.org (G. Mohan).
https://doi.org/10.55729/2000-9666.1120
2000-9666/© 2022 Greater Baltimore Medical Center. This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).

REVIEW ARTICLE

A Review of Left Ventricular Non-compaction
Cardiomyopathy (LVNC)

52

JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES 2022;12:51e63

REVIEW ARTICLE

(60%), followed by palpitations (18%), chest pain
(15%), syncope (9%), and prior stroke (3%). At
baseline, 31% of the patient population had New
York Heart Association (NYHA) functional class III
or IV heart failure. A systemic review illustrated that
the majority (56%) of the patient population diagnosed with LVNC was initially referred for heart
failure symptoms, and up to 11% were diagnosed
via screening.6 In the absence of census criteria, the
diagnosis of LVNC should be considered in patients
with distinctive trabeculations on cardiac echocardiography even without heart failure symptoms. In
clinical practice, an imaging (echocardiography &
cardiac magnetic resonance imaging) based ratio
between compacted and non-compacted (NC)
layers are currently used to diagnose this rare
phenotype.7,8 In addition to heart failure, thromboembolic events and arrhythmias are other major
complications of this rare phenotype. LVNC presenting with acute myocardial infarction (MI) has
rarely been reported in the literature.

2. Methods and results
We queried PubMed with “Isolated Noncompaction of the Ventricular Myocardium” [Mesh]
with an additional ﬁlter of ‘case reports’ in the last
20-years between 2012 and 2022, and we found a
total of 201 cases. On further screening, we included
only cases of left ventricular non-compaction in
adults. We reviewed a total of 60 cases of LVNC their presentation and treatments are tabulated
below.

3. Discussion
LVNC has been deﬁned as genetic cardiomyopathy (CMP) by the American Heart Association
(AHA) and categorized as nonclassiﬁed CMP by the
European Society of Cardiology. However, with
evolving evidence, LVNC is considered as a distinct
CMP. LVNC is classiﬁed into the following subgroups: iLVNC associated with normal systolic and
diastolic function; LVNC associated with LV
dysfunction and dilatation at onset; LVNC
morphology in patients fulﬁlling the criteria for
hypertrophic CMP, restrictive CMP, or dilated
CMP. In addition, LVNC can present as a transient
phenomenon in conditions like myocarditis or systemic lupus erythematosus (SLE). Different genes
(more than 10) that primarily code for cytoskeletal,
sarcomeric and mitochondrial proteins have been
implicated in genetic mutations of LVNC. The Heart
Failure Society of America 2018 guidelines recommended obtaining a family history up to three

generations and screening ﬁrst-degree relatives of
diagnosed LVNC patients.9 NCM is mostly diagnosed in the pediatric group, but isolated left ventricular noncompaction cardiomyopathy has been
reported in the elderly.10
3.1. Presentation
Heart failure was the most common presentation
and a common reason for hospitalization in NCM.6
Of the cases we reviewed, 63.3% of LVNC cases
were males, and 36.6% were females. The most
common presentation was heart failure (31 cases,
51.6%) followed by arrhythmias (12 cases, 20%),
angina (5 cases, 8.3%), and stroke (7 cases,
11.6%).(Fig. 3) Rare presentations included 1 case of
dissecting aneurysm, 1 of left ventricular thrombus,
2 of dizziness, and 1 of sepsis.
3.2. Diagnosis
The diagnosis of LVNC is primarily based on
morphological ﬁndings on transthoracic echocardiography (TTE) or cMRI. Jenni criteria and Chin or
St€
ollberger criteria are the two most commonly used
and widely accepted criteria to diagnose LVNC with
TTE. The sensitivity and speciﬁcity of morphological
criteria are unknown. In the absence of a census on
diagnostic criteria and nonspeciﬁc symptoms associated with LVNC, preventing the overdiagnosis of
LVNC should be a priority. NCM is most commonly
incidentally seen on TTE when working heart failure and cMRI can be used for anatomical delineation or when TTE is inconclusive.
3.3. Prognosis
The prognosis of LVNC is primarily dependent
on the severity of the disease (NYHA functional
class) at presentation. Depressed LV function and
late gadolinium enhancement (LGE) on cMRI are
the worst prognosis signs as will be seen in our
patient. A systematic review showed 14% mortality
at 39th month follow-up and ~50% of deaths were
from sudden cardiac arrest (SCA). Cardiovascular
complications at presentation, NYHA class III or
greater is a stronger predictor of cardiovascular
death with a hazard ratio of 20.6 and 8.8, respectively.11 Patients who are asymptomatic at the time
of the initial presentation have a better prognosis.
Follow up evaluation of the patients we reviewed
revealed that 58.3% of patients showed an
improvement; 10% deteriorated; 6.6% mortality
was observed and 25% of patients did not have a
follow-up (Fig. 4).

of them (Table 1). Screening TTE of ﬁrst degree
relatives is recommended.

3.4. Management
It is theorized that cardiac embolic events occur
due to thrombus formation in trabeculations in patients with severe systolic and diastolic dangiotensin-receptor blocker(s), or ARB(S)ysfunction and
can present with stroke or rarely as a coronary
embolism.12 Limited information regarding the
speciﬁc treatment of LVNC is available, and therapy
is mostly based on HF symptoms, LVEF, the burden
of thromboembolism, and the presence of arrhythmias. Heart failure should be managed as per
standard guidelines. Anticoagulation should not be
initiated in LVNC unless another indication (atrial
ﬁbrillation, intracardiac thrombus, or prior cardioembolic episode) is present. If a patient had an
episode of sustained ventricular tachycardia or
survived SCD, an ICD should be placed as a secondary prevention of SCA.13 However, the role of
ICD in primary prevention of SCD in LVNC with
EF<40% is unclear. Patients presenting with HFrEF
cardiac transplant should be considered earlier in
their disease progression as successful cardiac
transplants have been reported. In our review heart
failure medication such as beta blockers, angiotensin-converting enzyme inhibitors(ACEI), angiotensin-receptor blockers(ARBs) and diuretics lead to
improved ejection fraction and functioning class in
most patients. Anticoagulants were used in patients
where thrombosis was present during diagnosis.
Below is a table representing management strategies that were employed and the outcome from each

4. Case presentation
A forty-one-years old female presented with
substernal chest pain and exertional dyspnea. She
also reported occasional palpitations and generalized weakness. The patient's family history was not
obtained although it would have been extremely
pertinent. Her past medical history was signiﬁcant
for chest pain three years ago. However, diagnostic
workups including serial EKGs, troponin I, and
stress test were non-conclusive at that time. At
admission, her vital signs were: blood pressure 93/
63 mmHg, heart rate 58 beats/minute, respiratory
rate 16 breaths/minute, and oxygen saturation were
above 95% on room air. On physical examination,
she was alert without any distress, her neck examination did not reveal any bruit or jugular venous
distension. Heart examination showed regular S1
and S2, and no added sound or murmur was
auscultated. A lung examination showed good
bilateral air entry without any rhonchi or rales.
Peripheral pulses were palpable and regular, and
þ1 peripheral pitting edema was noted. EKG
showed normal sinus rhythm with premature atrial
contractions (PACs), left axis deviation, and STsegment and T wave changes suggestive of inferior
wall ischemia. Troponin I level was found to be
elevated, which peaked within 24 hours, Troponinmax 110.08 ng/ml and gradually declined over

Table 1. Clinical outcomes based on management instituted for LVNC.
Management administered

Improvement in
clinical status

Decline in
clinical status

No follow up

Stable

AC and HF medication
HF medication only
AC only
Anti-arrhythmic only
PCI and HF medication
Thrombectomy and AC
ICD only
Vasopressor therapy and diuretics
Pacemaker implantation and HF medication
CABG
Radio-frequency ablation
Mitral valve repair and HF medication
Mitral valve repair
Traditional medicine
LV restoration surgery
Transplant
Observation only
Unknown

5
8

1
1
1
1

4
1
4

1

1
1

1
1
3
1
1
1
1
3

1
1
1
1
1
1

1
1
5

3

* Two patients died close to presentation and were not included in this table.
AC - Anti-coagulation; HF - Heart failure; PCI - Per-cutaneous coronary interventions; CABG - Coronary artery bypass grafting; ICD Implantable cardioverter deﬁbrillator; LV - Left ventricle.
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2 days. Transthoracic echocardiography showed
moderate LV dilatation with severely reduced EF
(15e20%), and diffuse LV hypokinesis with a grade
III restrictive pattern. There was heavy trabeculation of LV involving 2/3rd LV endocardium and
wall thickness with sinusoidal tunnels perpendicular to LV wall. These morphological ﬁndings were
suggestive of LVNC/NCM. Transesophageal echocardiography (TEE) revealed mild spontaneous
echo contrast in the left atrial appendage, however,
no thrombus was visualized. Left heart catheterization showed a ﬁlling defect of the distal right
posterior descending artery (PDA), consistent with
a thrombus. Otherwise, normal coronary arteries
with severe diffuse cardiomyopathy, out of proportion to coronary artery disease (CAD) were seen.

Fig. 2. Contrast late enhancement study show heavy trabeculation of the
left ventricular apex, linear focus of hypointensity (arrow) consistent
with infract/scar.

The patient was treated conservatively and a cardiac MRI was obtained. Cardiac MRI(cMRI)
revealed moderate left ventricle dilatation with severe dysfunction and heavy trabeculations of LV
apex and mid-LV endocardium with a compact to
non-compact wall ratio of less than 1:2 consistent
with non-compaction cardiomyopathy (Fig 1).
Contrast enhancement study showed transmural
contrast late enhancement of mid inferior wall, a
ﬁnding consistent with transmural myocardial
infarction (Fig. 2).
4.1. Treatment & follow up

Fig. 1. Three chamber view demonstrates moderate left ventricular
dilation with compaction (arrow) to non-compaction (arrow head) ratio
of less than 1:2, consistent with left ventricular non-compaction.

The patient was treated conservatively with dual
antiplatelet, heparin, and statin therapy. She was
not able to tolerate beta-blocker and heart failure
standardized regime due to low blood pressure. She
was offered an implantable cardiac deﬁbrillator
(ICD) but she refused. Her clinical course deteriorated aggressively with multiple admissions due to
heart failure exacerbations. Three months later, she
got readmitted with cardiogenic shock requiring
ionotropic support. Her signs and symptoms did not
improve with vasopressors. Treatment escalation to
extracorporeal membrane oxygenation(ECMO) was
discussed with the patient, however, the patient
refused. She died due to sudden cardiac arrest, no
cardiopulmonary resuscitation was performed (the
patient was DNR).
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Fig. 3. Outcomes.

Fig. 4. Presentation.

5. Conclusions
LVNC and noncompaction cardiomyopathy
(NCM) are two distinct entities. A diagnosis of
LVNC should be considered in a patient who meets
the morphological criteria on TTE even without
clinical symptoms. However, if echocardiography is
inconclusive, a cMRI should be obtained that will
provide anatomic delineation. Screening (TTE) of
ﬁrst-degree relatives is recommended. Asymptomatic LVNC can be observed while symptomatic
LVNC should be treated with standard guidelines of
HF. LVNC presenting with acute myocardial
infarction (MI) can be related to poor outcomes,
however, more data is needed to establish the clinical implication of this presentation. Patients who
have poor prognostic features should be considered

for ICD and heart transplants earlier in the course of
their disease.
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the publication that can be reproduced for editorial
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Appendix.
Title

Age/Gender

Presentation

Management

Follow-up

Hugo Jesús Zetina-Tun,
Guillermo Careaga-Reyna
et al.

[Heart transplantation for the
treatment of isolated left
ventricular myocardial noncompaction. First case in
Mexico]

20M

Heart failure

Transplanted

Masanori Takamatsu, Keiji
Kamohara, et al.

Effect of Noncompacted
Myocardial Resection on Isolated Left Ventricular
Noncompaction

65M

Heart failure

Left anterior descending artery and diagonal artery contained thrombi that were
located and removed. Noncompacted trabeculae were
resected.

SBruno Ramos Nascimento,Daniel Furtado Vidigal,
et al.

Complete Atrioventricular
Block As the First Manifestation of Noncompaction of the
Ventricular Myocardium

32F

Complete AV block.

Dual-chamber pacemaker
implantation

Valentina Loriaa, Christian
Colizzib, et al.

Left Ventricular Noncompaction: Cause or Consequence of Myocardial
Disease? A Case Report and
Literature Review
Suppression of Storms of
Ventricular Tachycardia by
Epicardial Ablation of Isolated Delayed Potential in
Noncompaction
Cardiomyopathy
Case Report of Left Ventricular Noncompaction Cardiomyopathy Characterized by
Undulating Phenotypes in
Adult Patients
Case Report of Left Ventricular Noncompaction Cardiomyopathy Characterized by
Undulating Phenotypes in
Adult Patients
Isolated Left Ventricular
Noncompaction Causing
Stroke in a 30-Year-Old
Woman

57F

Heart failure

Discharged against medical
advise

Survival to 15 months
revealed class I New York
Heart Association, and endomyocardial biopsies did not
reveal evidence of acute
rejection.
Symptoms improved to New
York Heart Association class I
by his discharge on postoperative day 34. At followup echocardiography, the
thrombus and non-compacted layer had disappeared
At 18-month follow-up, the
patient is in NYHA functional
class I, using diuretics and
angiotensin-converting
enzyme inhibitor.
Discharged against medical
advise

65M

VT1 storms

Radiofrequency ablation.

2 weeks after RF ablation - no
VTs with sotalol 80 mg daily

57F

Heart failure

Percutaneous coronary intervention and heart failure
medication

In the subsequent years,
LVNC became less clear and
LV function gradually
improved

36M

Heart failure

6 months later improving
LVEF to 54.3%

30F

Stroke

Diuretics and beta-blockers
were used to treat congestive
heart failure, together with
anticoagulant for
thrombolysis
Anticoagulation with
warfarin

Masaomi Chinushi, Kenichi
Iijima, et al.

Wataru Miyake, Mayu Minemoto, et al.

Wataru Miyake, Mayu Minemoto, et al.

Giselle A. Baquero, Dustin J.
Colegrove, et al.

Six months later - no signiﬁcant changes. 28 months later
- substantial decline in LV
systolic function and marked
noncompaction of the
posterolateral, inferior, and
anterior walls.
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Author

Monu Rani, Rajesh Rajput,
et al.

Marwa Elnazeir, Lisa Nobel,
et al.

Bianca Olivia Cojan-Minzat,
Paul-Mihai Boarescu, et al.

Arun Gopi, Placid Sebastian,
et al.

65M

Stroke

diuretics and oral anticoagulation for secondary
stroke prevention and systemic embolism.

His brachial monoparesis was
improving, and the patient
has been doing ﬁne on
pharmacotherapy.

63M

Stroke; Heart failure

tPA; eventually apixaban,
aspirin and statin

3-month followup - residual
visual ﬁeld deﬁcits. Cardiac
outcome improved EF of 40%

52M

Heart failure

Diuretic and vasopressor
therapy

Died from a worsening of the
disease

32M

Arrythmia

Catheter ablatio

15 months of follow-up - no
more episodes of palpitations
or syncope.

19M

Heart failure

Tiroﬁban bolus followed by
infusion for 24 h and
continued on heparin.
Lifestyle cares, trimetazidine(improves myocardial
glucose utilization through
inhibition of fatty acid metabolism) Shensongyangxin.
traditional Chinese medicine,
containing ginseng, ophiopogon japonicus, Schisandra,
and red sage root
Thrombolysis and
anticoagulation

Not available

Mitral valve repair for MVP
and ascending aorto-bifemoral bypass

LVEF was increased to 41.8 %
post-op

Routine treatment for cardiac
failure

EF improved to 40% on
echocardiography

Yuechun Shen, Xinchun Li,
et al.

Myocardial Noncompaction
Presenting With Myocardial
Bridge

34M

Angina

Claudia St€
ollberger, Josef
Finsterer et al.

Embolism from noncompaction to different
vascular territories
Left ventricular noncompaction complicated by
mitral valve prolapse: report
of a case
Isolated Non-Compaction of
the Left Ventricle in a Patient
with New-Onset Heart Failure: Morphologic and Functional Evaluation with
Cardiac Multidetector
Computed Tomography

26M

Emboli leading to stroke,
renal artery occlusion and
PAD
Heart failure

Takashi Igarashi, Shinya
Takase, et al.

Heon Lee, Seok-Yeon Kim,
et al.

31M

72M

Atrial ﬁbrillation and heart
failure

EF improved to 77%. Other
parameters from echocardiograph and electrocardiograph
are not changed.

Not available
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Takafumi Ogawa, Sho Ogata ,
et al.

Non-compaction of ventricular myocardium with polycystic kidney disease with
cardiogenic cerebral
embolism
Left Ventricular Noncompaction Cardiomyopathy
as a Potential Cause of Bilateral Posterior Cerebral Artery
Stroke e a Rare and Unique
Clinical Occurrence
Left ventricular noncompaction with pulmonary
capillary hemangiomatosislike lesions: case report
Catheter ablation of a right
posterior accessory pathway
in a patient with left ventricular noncompaction: A case
report
A rare malady with a rarer
complication

(continued on next page)
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(continued )
Title

Age/Gender

Presentation

Management

Follow-up

Ling Han, Jing-Gang Luo,
et al.

Left Ventricular Noncompaction Combined With
EpinephrineSecreted Pheochromocytoma Inducing
Heart Failure

28F

Phaeochromocytoma and
heart failure symptoms.

HF treatment with bed rest,
sodium nitroprusside, and
diuretics,

Yusuf Izzettin Alihanoglu,
Ismail Dogu Kilic, et al.

Sustained ventricular tachycardia in a patient with isolated non-compaction
cardiomyopathy
An interesting case of cryptogenic stroke in a young man
due to left ventricular noncompaction: role of cardiac
MRI in the accurate diagnosis
Left ventricular non-compaction and dyssynchrony

25F

Heart failure

28M

Stroke

Amiodarone, anticoagulant
therapy and heart failure
treatment with beta-blockers,
ACEI, and diuretics.
No Rx. Since the patient
remained asymptomatic, he
was advised to follow up with
a cardiologist.

After two months, re-hospitalized, and resection of the
pheochromocytoma was performed. All oral drugs were
ceased after the operation. F/
u echo continued to show
LVNC, however, the systolic
function of the myocardium
was signiﬁcantly improved,
and LVEF was increased to
56%.
None

43M

Heart failure

Dobutamine was started.
Digoxin, Hydralazine, Lasix,
and Captopril were initiated
and titrated.

An adult patient with left
ventricular noncompaction
detected on radionuclide
myocardial perfusion
imaging
Daily 10 mg rivaroxaban as a
therapy for ventricular
thrombus related to left ventricular non-compaction
cardiomyopathy
Aortic valve replacement for
aortic regurgitation with rare
left ventricular noncompaction

51M

Ventricular tachycardia

Not available

His symptoms improved
from NYHA class IV to III.
The condition stabilized and
the patient was discharged
home.
Not available

43M

Tthrombosis in left ventricle

Rivaroxaban and beta-blocker

Not available

74F

Heart failure

Aangiotensin-converting
enzyme inhibitor, diuretic,
and aortic valve replacement.
Discharged on an oral anticoagulant, heart failure
medication and a beta-blocking agent

Remained free of cardiac
events at two years when the
symptoms of heart failure
improved to NYHA functional class 1. The characteristic features of noncompaction remained
unchanged

Arun Kannan, Anindita Das,
et al.

Kana Fujikura, Dennis Finkielstein, et al.

Jian-Ming Li, Ting Li, et al.

Huan Sun, Qini Zhao, et al.

Hideyuki Tanaka, Tatsunori
Kimura, et al.

Not available
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Author

Aneurysm of the right sinus
of Valsalva dissecting into the
interventricular septum, submitral aneurysm and left
ventricular non-compaction:
three rare diseases in the
same patient

24M

Dissecting aneurysm

Nikhil Kumar, Christopher A
Troianos, et al.

Left Ventricular Assist Device
Insertion in a Patient With
Biventricular Noncompaction
Cardiomyopathy, Ebstein
Anomaly, and a Left Atrial
Mass: A Case Report

21F

Heart failure a large LA mass.

Rafał Dąbrowski, Maciej
Sterli
nski, et al.

Cardiac resynchronization
therapy in an elderly patient
with left and right ventricular
noncompaction

57M

Heart failure

Josef Finsterer, Claudia
St€
ollberger et al.

Left ventricular hypertrabeculation/noncompaction
in an Eritrean war invalid
with neuromuscular disease
Coronary microﬁstulae associated with non compacted
myocardium: A rare cause of
myocardial ischemia unraveled by a multimodality imaging approach
Pregnancy and treatment
outcome in a patient with left
ventricular non-compaction

52M

Heart failure

61M

Chest pain

Metoprolol twice-a-day and
was discharged without
symptoms.

18-months follow-up visit doing well and does not
report further episodes of
chest pain.

37F

Heart failure

Stable

a ‘tiger heart’ distinct variant
of left ventricular noncompaction
Spongious Ischemic
Myocardium

30M

Asymptomatic,with
arrhythmia

Suppression of lactation with
bromocriptine, together with
standard heart failure
management
Observation

38M

Heart failure

Inotropes, diuretics, vasodilator, and coronary artery
bypass surgery.

51F

Dizziness

Conventional heart failure
medical therapy and
implantable cardioverterdeﬁbrillator.

Rahul D. Sawant, Leisa J.
Freeman , et al.

Felix K Wegner , GerhardPaul Diller , et al.
Gonzalo Navarrete , Eduardo
Pozo ,et al.

Nay Aung , Filip Zemrak
,et al.

LV Noncompaction Cardiomyopathy or Just a Lot of
Trabeculations?

Stable post-op

A follow-up of 32 months
have shown good response to
CRT-D treatment.

Not available

After 52 months, the patient
remained stable and
asymptomatic.
Six months after surgery,
under optimal medical therapy, the patient was New
York Heart Association functional class I.
2 years later demonstrated
progressive LV disease after
that ICD was placed

JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES 2022;12:51e63

Alessio Lillia, Marco Chiocciolia, et al.

Diuretics, angiotensin-converting enzyme inhibitors,
and digitalis, with dramatic
improvement in symptoms.
He was proposed for surgery
but refused and was discharged in New York Heart
Association class I.
Medical management for
heart failure and the placement of an intra-aortic
balloon pump -> AFib with
Thrombus in the right upper
pulmonary vein. The entire
mass was removed - > LVAD
and surgical removal of
thrombus
Cardiac resynchronization
therapy (CRT-D) was introduced. 1 episode of ven- tricular tachycardia terminated
by a cardioverter intervention. Heart failure medication
on discharge
Not available

The patient died one year
after the ﬁrst admission.

Humberto Morais
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(continued )
Title

Age/Gender

Presentation

Management

Follow-up

Nay Aung , Filip Zemrak
,et al.

LV Noncompaction Cardiomyopathy or Just a Lot of
Trabeculations?

32M

Palpitations

Observation

Dipesh Pradhan , Chen Liping, et al.

An unusual case of myocardial noncompaction involving
both ventricles
Aortic root replacement in a
patient with left ventricular
noncompaction

18M

Heart failure

57F

Heart failure

ACE inhibitor, aldosterone
antagonist, and thiazide
diuretic
Coronary artery bypass graft

2 years later demonstrated an
increase in LV internal dimensions and decline in LV
systolic function
Not available

Michael E Pitzer , Peter H
Seidenberg , et al.

Asymptomatic Left Ventricular Noncompaction d Implications for Athletic
Participation

18M

asymtomatic

Observation

Giovanni Pulignanoa , Maria
Denitza , et al

Noncompaction and embolic
myocardial infarction: The
importance of oral
anticoagulation

67F

Heart failure

IV inotropes and diuretics,
implantable cardioverterdeﬁbrillator and was discharged in NYHA class II,
under standard heart failure
therapy including oral anticoagulation (OAC),

Daniele Muser , Gaetano
Nucifora , et al

Clinical Spectrum of Isolated
Left Ventricular Noncompaction: Thromboembolic Events, Malignant Left
Ventricular Arrhythmias, and
Refractory Heart Failure
Isolated noncompaction of
right ventricle–a case report

17M

Stroke

Implantable cardioverterdeﬁbrillator

19M

Heart failure

Non-compaction cardiomyopathy in an asymptomatic
athlete
Rare case of mitral annulus
disjunction and noncompaction-like myocardium
Disappearance of left ventricular hypertrabeculation/
noncompaction and sudden
death in a patient with Turner
mosaic syndrome

20M

Asymptomatic

Treated with heart failure
medications, anticoagulants,
and drugs to control rapid
ventricular rate
Observation

74M

Heart failure

Not available

Not available

5M

Acute coronary syndrome

Coronary artery bypass
grafting

Death within 6 month

Jamil Hajj-Chahine ,
G
eraldine Allain,et al.

Daniele Muser , Gaetano
Nucifora , et al

Margaret Kapor Manus ,
Satyajeet Roy , et al
Bryan E-Xin Tan , Mallory
Balmer-Swain , et al
Johann Altenberger , Georg
Hasenauer ,et al

6 months later, she was doing
well, and the echocardiogram
revealed a good functioning
prosthetic
valve; the left ventricle ejection fraction increased to 50%.
The patient was cleared for
participation in football with
close monitoring and repeat
echocardiography to be
completed in 1 year
2 years after stopping anticoagulation , EF fell to 15%,
Coronary angiography
revealed a thrombotic occlusion of the mid segment of
the left anterior descending
artery,death followed 25 days
later
Five years later, he underwent cardiac transplantation
for worsening heart failure

Not available

6-months later he remains
asymptomatic
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Author

David C Peritz , Aaron
Vaughn ,et al

Ashraf Alazzoni , Vidhya Nair
, et al

Mareomi Hamada , Yoshimi
Takamura , et al

Costin Nicolae Ionescu ,
Diane Turcot

Alberto Cecconi , María Jos
e
Olivera , et al

Tomoaki Hirose , Tetsuji
Kawata , et al

Mariola Szulik , Tomasz
Kukulski, et al
David Schibilsky , Karin
Klingel ,et al

Josef Finsterer , Martina
Dumser

Mumur

Observation

The patient returned to full
athletic participation, and
reevaluated annually.

26M

Heart failure and ischemic
limb

29F

Stroke

On the ﬁfth postoperative day
the pateint developed ventricular ﬁbrillation followed
by pulseless electric activity,
which did not respond to full
and prolonged resuscitative
effort
Unavailable

Left ventricular non-compaction presenting with heart
failure and intramural
thrombus
Left ventricular noncompaction mimicking hypertrophic obstructive
cardiomyopathy

28M

Heart failure

30F

Angina

Intravenous infusion of
unfractionated heparin echocardiographic assessment, the
patient successfully underwent catheter-based embolectomy of the aorta and iliac
arteries
Started on oral
anticoagulants.
Lisinopril 5 mg daily and
furosemide 40 mg, and intravenous heparin Low-dose
metoprolol
Cibenzoline and after 3
months - LV restoration
surgery

Left ventricular noncompaction and aneurysm
revealed by left
ventriculography
Epicardial lipomatous hypertrophy with ventricular
septum separation and
myocardial non-compaction:
a new cardiomyopathy?
Aortic valve replacement in a
patient with left ventricular
noncompaction

60M

Syncope

Oral anticoagulation and
(ICD)

60F

Angina

Monitor

The patient was asymptomatic at the 6-month follow-up

62F

Heart failure

Medical management of heart
failure and aortic valve
replacement

22F

Arhytthmia

Amiodarone, and lignocaine

2 years after the operation
showed trivial mitral regurgitation and improvements in
LV ejection fraction to 59%
Death on the 5th day

34M

Arhythmia

88F

Sepsis

Amiodarone, sotalol, and
ﬁnally ranolazine. Finally had
Intraoperative epicardial
ablation
Antibiotics and pressors for
sepsis

Long QT syndrome and left
ventricular non-compaction
Successful Surgical Treatment of an Electrical Storm in
a Patient With Atypical Noncompaction Cardiomyopathy
Noncompaction in a septic
heart, missed on
echocardiography

3 months revealed stable
LVEF of 15%. and ICD placed

After the operation, her systolic murmur and clinical
symptoms disappeared. The
extent of LVNC decreased
and intertrabecular
recesses disappeared
Unavailable

Resolution after Six months
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Hany Younan , Raed
Alroughani , et al
Madan Raj Aryal , Madan
Badal , et al

18M

Hypertrabeculation vs Left
Ventricular Noncompaction
on Echocardiogram
A Reason to Restrict Athletic
Participation
noncompaction reaction

Multiorgan failure and death
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Age/Gender

Presentation

Management

Follow-up

Giuseppina Novo , Gregory
Dendramis, et al

Left ventricular noncompaction presenting like a
double-chambered left
ventricle
Primary electrical disorder or
primary cardiomyopathy? A
case with a unique association of noncompaction cardiomyopathy and
cathecolaminergic polymorphic ventricular tachycardia caused by ryanodine
receptor mutation
Can hypertrophic cardiomyopathy and noncompaction
left ventricle coexist in a single patient?
Unusual myocardial late
gadolinium enhancement in
isolated noncompaction
cardiomyopathy

24F

Asymptomatic

Observation

At 1 year follow up - remains
asymptomatic

39F

Heart failure

Dual chamber pacemakerdeﬁbrillator implantation
with further titrating of bblocker therapy and ablation

resolution of the symptoms
within 6 months

50F

Heart failure

Unavailable

Unavailable

19M

Heart failure

Unavailable

38F

Heart failure

Oral anticoagulation, in
addition to the standard
therapy for heart failure,
based on the notion of mural
LV thrombi revealed by the
CMR. Cardiac resynchronization therapy/deﬁbrillator
was performed 6 months later
Angiotensin-convertingenzyme inhibitors, diuretics,
amiodarone, and
anticoagulants.

67 M

Heart failure

Cardiac resynchronization
therapy and ramipril, bisoprolol, furosemide and
spironolactone

Follow-up at 32 months
showed good response to
cardiac resynchronization
therapy

Zs
oﬁa Szentp
ali , Tamas SziliTorok , et al

Anita Sadeghpour , Shadi
Faghihi, Azin Alizadehasl

Sherif Moustafa David J Patton, et al

Wei-Ting Chang , Yi-Shan
Tsai et al

Rafał Dąbrowski, Maciej
Sterli
nski , et al.

Left ventricular noncompaction cardiomyopathy:
an under-recognized disease
diagnosed by echocardiography and computed
tomography
Cardiac resynchronization
therapy in an elderly patient
with left and right ventricular
noncompaction

4 days later due to a right
middle cerebral extensive
infarction and died of intractable increased intracranial
pressure
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